Literature DB >> 26086212

A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations.

Rakesh K Pathak1, Shanta Dhar1.   

Abstract

A single magic bullet is not enough for treatment of metastatic cancers. However, administration of a combination of free drugs can be extremely challenging because of the inability to control the correct choice of dosages and definitive delivery of the effective drug ratio at the target tissue due to the differences in pharmacokinetics and biodistribution of individual drugs. Here we report an engineered biodegradable polymer containing combination therapeutics that can be self-assembled into a controlled release nanoparticle with abilities to deliver multiple therapeutics in a predefined ratio following temporal release patterns. This platform technology can lead to a rationally designed combination therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26086212     DOI: 10.1021/jacs.5b03078

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

1.  Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective Treatment of Platinum-Resistant Ovarian Cancer.

Authors:  Christopher Poon; Xiaopin Duan; Christina Chan; Wenbo Han; Wenbin Lin
Journal:  Mol Pharm       Date:  2016-10-21       Impact factor: 4.939

2.  A Theranostic Nanocomplex Combining with Magnetic Hyperthermia for Enhanced Accumulation and Efficacy of pH-Triggering Polymeric Cisplatin(IV) Prodrugs.

Authors:  Yang Qu; Zhiqi Wang; Miao Sun; Tian Zhao; Xuanlei Zhu; Xiaoli Deng; Man Zhang; Ying Xu; Hongfei Liu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-14

Review 3.  The Platin-X series: activation, targeting, and delivery.

Authors:  Uttara Basu; Bhabatosh Banik; Ru Wen; Rakesh K Pathak; Shanta Dhar
Journal:  Dalton Trans       Date:  2016-08-16       Impact factor: 4.390

Review 4.  Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

Authors:  Ru Wen; Bhabatosh Banik; Rakesh K Pathak; Anil Kumar; Nagesh Kolishetti; Shanta Dhar
Journal:  Adv Drug Deliv Rev       Date:  2016-01-09       Impact factor: 15.470

5.  New formulation of old aspirin for better delivery.

Authors:  Akil A Kalathil; Anil Kumar; Bhabatosh Banik; Timothy A Ruiter; Rakesh K Pathak; Shanta Dhar
Journal:  Chem Commun (Camb)       Date:  2016-01-04       Impact factor: 6.222

Review 6.  Nanoparticle formulations of cisplatin for cancer therapy.

Authors:  Xiaopin Duan; Chunbai He; Stephen J Kron; Wenbin Lin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-02-05

7.  Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.

Authors:  Shouhai Wu; Tianpeng Zhang; Jingsheng Du
Journal:  Drug Des Devel Ther       Date:  2016-10-25       Impact factor: 4.162

8.  Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.

Authors:  Yu-Guo Yuan; Sangiliyandi Gurunathan
Journal:  Int J Nanomedicine       Date:  2017-09-05

Review 9.  Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.

Authors:  Ru Wen; Afoma C Umeano; Lily Francis; Nivita Sharma; Smanla Tundup; Shanta Dhar
Journal:  Vaccines (Basel)       Date:  2016-06-01

10.  Multifunctional quantum dot DNA hydrogels.

Authors:  Libing Zhang; Sae Rin Jean; Sharif Ahmed; Peter M Aldridge; Xiyan Li; Fengjia Fan; Edward H Sargent; Shana O Kelley
Journal:  Nat Commun       Date:  2017-08-29       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.